Eric Dane, who died Thursday at 53 after a nearly yearlong battle with amyotrophic lateral sclerosis (ALS), candidly revealed his vow to “combat” the disease in one of his final on-camera interviews ...

If you've ever said you just "have no rhythm," it turns out you might not have any excuse. A new study found that infants can recognize and learn the rhythm of music within just 48 hours of first ...

AMSTERDAM & BOSTON--(BUSINESS WIRE)--VectorY Therapeutics, a leader in vectorized antibody therapies for neurodegenerative diseases, announced today that the first participant has been dosed in its ...

A significant discovery by Case Western Reserve University researchers could change how doctors treat two of the most devastating neurodegenerative diseases. The team identified a link between gut ...

Rusty Bennett's wife died nearly three years after she was diagnosed with ALS. The couple shares two kids together, sons Lincoln, 9, and William, 7 The Ananda Pivot/Instagram On Jan. 13, Sara Bennett ...

Before she died in January, the late content creator posted about the advice and heartfelt words that she left for her two kids, sons Lincoln, 9, and William, 7 The Ananda Pivot/Instagram Content ...

This year marks a decade for ALS New Mexico’s annual “Hearts on Your Sleeve” fashion show. Not only will they put on a runway show featuring local boutiques and models, but they will also be raising ...

A pharmaceutical company based in New Jersey that’s known for its FDA-approved treatment for ALS is set to be acquired for $2.5 billion. Tanabe Pharma America, which operates a U.S. headquarters in ...

Forbes contributors publish independent expert analyses and insights. News and opinion about video games, television, movies and the internet. It really does not seem like all that long ago we were ...

Two major trials investigating the potential of the psychedelic drug LSD for reducing anxiety are set to conclude in 2026. Scientists are feeling positive after the drug’s success in an earlier-stage ...

Pharma's end-of-year dealmaking flurry is not showing signs of slowing, as, now, two Japanese drugmakers have joined the action with a multibillion-dollar asset transfer agreement. Monday, Shionogi ...

Years ago, when venture capitalist Jon Medved took an interest in backing various health tech startups, he had no idea that one day, he would need them to improve his own quality of life. Israel’s ...